MDS Virtual Congress 2020 » Parkinson's Disease and Lewy Body Dementia

A brain signature of prodromal Lewy body dementia

S. Rahayel, R. Postuma, J. Montplaisir, B. Mišić, C. Tremblay, C. Yao, M. Gaubert, J. Carrier, O. Monchi, F. Blanc, S. Chouinard, M. Panisset, A. Dagher, J.F Gagnon (Montreal, QC, Canada)

Clinical factors associated with neuronal loss in the substantia nigra

R. Yilmaz, E. Bayram, C. Akbostanci (Ankara, Turkey)

Comparison of 123I-MIBG myocardial scintigraphy and 123I-FP-CIT SPECT between dementia with Lewy bodies and Parkinson’s disease

Y. Asahara, S. Miyagawa, M. Suzuki (Tokyo, Japan)

Confrontation Naming Deficit in Lewy Body Dementia Patients with Alzheimer’s Disease Co-Pathology

E. Howard, D. Irwin, K. Rascovsky, N. Nevler, S. Shellikeri, D. Mechanic-Hamilton, T. Tropea, A. Chen-Plotkin, A. Siderowf, D. Weintraub, L. Shaw, J. Trojanowski, M. Grossman, K. Cousins (Philadelphia, PA, USA)

Development and Characterization of an Ultrasensitive Assay Platform for Detection of PD Associated alpha-Synuclein Oligomers in Human Blood

D. Robakis, A. Chiu, B. Chang, R. Rubenstein (Brooklyn, NY, USA)

Differential impact of Lewy body disease and Alzheimer’s disease neuropathology on cognition

S. Ryman, M. Yutsis, L. Tian, V. Henderson, T. Montine, D. Salmon, D. Galasko, K. Poston (Stanford, CA, USA)

Discrimination of alpha-synuclein strains and sub-strains in Synucleinopathies

M. Shahnawaz, A. Mukherjee, S. Pritzkow, N. Dinamarca, F. Wang, P. Rabadia, C. Soto (Houston, TX, USA)

Dyskinesia and bradykinesia severity patterns in Parkinson’s disease using a wearable sensor

D. van Wamelen, T. Bendriss-Otiko, A. Podlewska, V. Leta, C. Lazcano Ocampo, D. Trivedi, K. Ray Chaudhuri (London, United Kingdom)

Identifying Neuropsychiatric Profiles in Parkinson’s disease, Dementia with Lewy Bodies and Alzheimer’s disease

D. Smith, P. Donaghy, B. Galna, A. Yarnall, J.P Taylor, D. Burn, A. Thomas, L. Rochester, R. Mc Ardle, R. Lawson (Newcastle upon Tyne, United Kingdom)

Multimodal model of Parkinson’s disease highlights differences in progression profiles of RBD patients

R. Couronné, A. Valladier, M. Vidailhet, J.C Corvol, S. Lehericy, S. Durrleman (Paris, France)

Prevalence of Neuropsychiatric Symptoms in the Prodromal Stages of Dementia with Lewy Bodies and Parkinson’s Disease Dementia

K. Wyman-Chick, L. Erickson, D. Weintraub, M. Rosenbloom, T. Barclay, M. Barrett (St Paul, MN, USA)

Relationship Between a-syn RT-QuIC and a-syn Neuropathologic Burden in Dementia with Lewy Bodies

D. Coughlin, C. Orru, B. Groveman, A. Hiniker, R. Rissman, B. Caughey, D. Galasko (San Diego, CA, USA)

Role of Sex in Parkinson’s Disease Progression

E. Bayram, S. Eberly, D. Oakes, I. Litvan (La Jolla, CA, USA)

Serum Neurofilament light chain levels and disability milestones in Lewy body diseases

A. Pilotto, A. Imarisio, F. Conforti, A. Lupini, G. Giannì, S. Gipponi, E. Cottini, A. Scalvini, S. Masciocchi, S. Nocivelli, R. Grasso, R. Turrone, B. Borroni, M. Rizzetti, L. Bonanni, M. Pizzi, A. Bellucci, E. Garraffa, H. Zetterberg, N. Ashton, A. Hye, A. Padovani (Brescia, Italy)

Sex Moderates the Effects of Neurofibrillary Tangles on Cognition for Diffuse Lewy Body Pathology

E. Bayram, I. Litvan (La Jolla, CA, USA)

The role of low contrast visual acuity in cognitive performance in Lewy body diseases

R. Del Pino, M. Acera, A. Murueta-Goyena, O. Lucas-Jiménez, N. Ojeda, N. Ibarretxe-Bilbao, J. Peña, P. Reyero, J. Cortés, B. Tijero, M. Galdós, J.C Gómez-Esteban, I. Gabilondo (Barakaldo, Spain)

Type 2 diabetes mellitus may worsen severity of motor symptoms in people with Parkinson’s disease

A. Ben-Joseph, T. Haque, D. Gallagher, C. Budu, R. Chaudhuri, C. Simonet, A. Noyce (London, United Kingdom)

Unraveling the role of amylin oligomers in synucleinopathies

I. Martinez Valbuena, R. Valenti Azcarate, C. Caballero, I. Marcilla Garcia, I. Amat-Villegas, J. Sanchez, G. Marti-Andres, L. Armengou, M.R Luquin Piudo (Pamplona, Spain)